NCT03649984 is a NA clinical trial of Symptom Navi© Program in Cancer, sponsored by Manuela Eicher.

Who is sponsoring NCT03649984?

NCT03649984 is sponsored by Manuela Eicher.

What drugs are being tested in NCT03649984?

Interventions in NCT03649984: Symptom Navi© Program.

Is NCT03649984 still recruiting?

NCT03649984 is currently completed. Last updated 24 August 2020.

Last reviewed 2020-08-24 · How we verify

NCT03649984

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Implementation of the Symptom Navi© Program

Completed NA Last updated 24 August 2020

What this trial tests

NA trial testing Symptom Navi© Program in Cancer in 134 participants. Completed in 12 April 2019.

Timeline

17 October 2017

Primary endpoint
12 April 2019

12 April 2019

Quick facts

Lead sponsor	Manuela Eicher
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	134
Start date	17 October 2017
Primary completion	12 April 2019
Estimated completion	12 April 2019
Sites	9 locations across Switzerland

Drugs / interventions tested

Symptom Navi© Program

Conditions studied

Cancer — all drugs for Cancer →

Sponsor

Manuela Eicher

Who can join

18 and older, any sex, with Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Symptom Navi© Program is a program to support symptom self-management of 16 core symptoms frequently experienced by patients in outpatient oncology units.The current study aims to pilot test the implementation of the Symptom Navi© Program under real-life conditions by evaluating procedures, testing preliminary effectiveness and assessing potential unintended effects using a cluster-randomised waitlist design complemented by qualitative methods.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Development and implementation strategies of a nurse-led symptom self-management program in outpatient cancer centres: The Symptom Navi© Programme.
Bana M, Ribi K, Kropf-Staub S, Näf E, et al · · 2020 · cited 9× · PMID 31954227 · DOI 10.1016/j.ejon.2019.101714
Implementation of the Symptom Navi © Programme for cancer patients in the Swiss outpatient setting: a study protocol for a cluster randomised pilot study (Symptom Navi© Pilot Study).
Bana M, Ribi K, Kropf-Staub S, Zürcher-Florin S, et al · · 2019 · cited 7× · PMID 31289075 · DOI 10.1136/bmjopen-2018-027942
Pilot Testing of a Nurse-Led Basic Symptom Self-management Support for Patients Receiving First-Line Systemic Outpatient Anticancer Treatment: A Cluster-Randomized Study (Symptom Navi Pilot Study).
Bana M, Ribi K, Peters S, Kropf-Staub S, et al · · 2021 · cited 5× · PMID 34507338 · DOI 10.1097/ncc.0000000000000995

Verify or expand the search:

Other recruiting trials for Cancer

Currently open trials in the same condition.

NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting

Other Manuela Eicher trials

Trials by the same sponsor.

NCT05530187 — ePRO-based Model of Care to Manage and Monitoring Symptoms of Cancer Patients Treated With Immune Checkpoint Inhibitors · NA · unknown
NCT03651921 — Testing of the Cancer Thriving and Surviving Breast Cancer Program · NA · completed
NCT03045003 — Testing Two Different Intensities of an Intervention to Enhance REsilience and to Reduce SupportIve Care Needs in Cancer · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03649984 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Manuela Eicher
Last refreshed: 24 August 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03649984.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing